# 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers

> **NCT05113264** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 60 (actual)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DEVICE:** 'Penny' via Memora Platform

## Key facts

- **NCT ID:** NCT05113264
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-02
- **Primary completion:** 2024-11-05
- **Final completion:** 2024-11-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05113264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05113264, "'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05113264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*